Insgesamt stellen sich die GLP-1-RA als hochwirksame glukosesenkende Medikamente dar, die zustzlich eine erhebliche und stoffwechselrelevante Gewichtsreduktion untersttzen knnen und bei einer recht groen Subpopulation aller Menschen mit T2D schwerwiegende kardiovaskulre Ereignisse verhindern knnen
With multiple expansion projects across France, China and the US, Novo Nordisk aims to mitigate the ongoing shortage of GLP-1 drugs and keep up with its booming demand
Abstracts presented at the 13th international congress of inborn errors of metabolism - ICIEM 2017
Google and the SEC I dont know who made the conscious decision to archive SEC news digests in 1991, or who prompted for those digests to be uploaded to the SECs website, but what I do know is that Google indexes those news digests, and on page 5 of Issue 91-212 dated November 1, 1991 , the following entry exists: I did my absolute best to find out more about this case, but I have limited resources, and while it might not be proof in isolation, it confirms all of my priors about Mr
"Amgen to Pay Lower Royalties on New Drug : Pharmaceuticals: It costs the Thousand Oaks firm $50 million to alter its agreement with a research center
By leveraging nanoscience, researchers have developed sophisticated delivery systems-including liposomes, nanoemulsions, and polymeric nanoparticles-that encapsulate nutraceuticals, shielding them from degradation and enabling controlled, targeted release